Chirenje Z M, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N
Department of Obstetrics and Gynaecology, University of Zimbabwe, Harare, Zimbabwe.
Int J STD AIDS. 2002 Nov;13(11):765-8. doi: 10.1258/095646202320753727.
A cross-sectional study was conducted on women attending family planning clinics in Harare, Zimbabwe to determine the prevalence of cervical neoplasia among HIV-1 positive women relative to an HIV-1 negative control group. Five hundred and fifty four women were recruited and the prevalence of HIV-1 was 36.8%. Cervical cytology was abnormal in 25.6% of HIV-infected women compared to only 6.7% HIV-1 seronegative women. Cervical neoplasia was significantly associated with HIV infection (chi(2)=42.4, P<0.001). Cellular changes typical of HPV infection (koilocytocis) were recorded in 6.4% of HIV infected women compared with 1.7% of HIV-1-uninfected women (chi(2)=8.43, P=0.004). HIV-1-positive women had twice the risk of having abnormal cervical cells than HIV-negative women (relative risk 2.47, odds ratio 10.14, P<0.001). Therefore the introduction of national cervical screening programme in HIV-1 endemic countries like Zimbabwe where the highest burden of pre-malignant lesions is among HIV-1-infected women needs careful planning because these women have other competing health needs including high rates of opportunistic infections.
在津巴布韦哈拉雷的计划生育诊所对前来就诊的女性进行了一项横断面研究,以确定相对于HIV-1阴性对照组,HIV-1阳性女性中宫颈肿瘤的患病率。招募了554名女性,HIV-1患病率为36.8%。25.6%的HIV感染女性宫颈细胞学异常,而HIV-1血清阴性女性中这一比例仅为6.7%。宫颈肿瘤与HIV感染显著相关(χ²=42.4,P<0.001)。6.4%的HIV感染女性记录到典型的HPV感染细胞变化(挖空细胞),而HIV-1未感染女性中这一比例为1.7%(χ²=8.43,P=0.004)。HIV-1阳性女性宫颈细胞异常的风险是HIV阴性女性的两倍(相对风险2.47,优势比10.14,P<0.001)。因此,在像津巴布韦这样的HIV-1流行国家引入全国性宫颈筛查计划需要仔细规划,因为在这些国家,癌前病变负担最重的是HIV-1感染女性,而这些女性还有其他相互竞争的健康需求,包括机会性感染的高发生率。